153 related articles for article (PubMed ID: 21557245)
1. Prostaglandin (PG)E2 exhibits antifibrotic activity in vocal fold fibroblasts.
Zhou H; Felsen D; Sandulache VC; Amin MR; Kraus DH; Branski RC
Laryngoscope; 2011 Jun; 121(6):1261-5. PubMed ID: 21557245
[TBL] [Abstract][Full Text] [Related]
2. Effects of transforming growth factor-beta1 on human vocal fold fibroblasts.
Branski RC; Barbieri SS; Weksler BB; Saltman B; Krishna P; Kraus DH; Broadbelt NV; Chen J; Poppas DP; Felsen D
Ann Otol Rhinol Laryngol; 2009 Mar; 118(3):218-26. PubMed ID: 19374154
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 inhibition of keloid fibroblast migration, contraction, and transforming growth factor (TGF)-beta1-induced collagen synthesis.
Sandulache VC; Parekh A; Li-Korotky H; Dohar JE; Hebda PA
Wound Repair Regen; 2007; 15(1):122-33. PubMed ID: 17244328
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms Underlying the Antifibrotic Potential of Estradiol for Vocal Fold Fibrosis.
Ozawa S; Mukudai S; Sugiyama Y; Branski RC; Hirano S
Laryngoscope; 2021 Oct; 131(10):2285-2291. PubMed ID: 33378560
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy induces antifibrotic alterations in primary human vocal fold fibroblasts.
Zhang C; Wang J; Chou A; Gong T; Devine EE; Jiang JJ
Laryngoscope; 2018 Sep; 128(9):E323-E331. PubMed ID: 29668038
[TBL] [Abstract][Full Text] [Related]
6. Stem Cell-Mediated Paracrine Signaling Alters Fibroplasia in Human Vocal Fold Fibroblasts in Vitro.
Hiwatashi N; Bing R; Kraja I; Branski RC
Ann Otol Rhinol Laryngol; 2017 Aug; 126(8):581-588. PubMed ID: 28635301
[TBL] [Abstract][Full Text] [Related]
7. Antifibrotic effects of eupatilin on TGF-β1-treated human vocal fold fibroblasts.
Park SJ; Choi H; Kim JH; Kim CS
PLoS One; 2021; 16(3):e0249041. PubMed ID: 33765087
[TBL] [Abstract][Full Text] [Related]
8. Changes in cytokine signaling and extracellular matrix production induced by inflammatory factors in cultured vocal fold fibroblasts.
Lim X; Bless DM; Muñoz-Del-Río A; Welham NV
Ann Otol Rhinol Laryngol; 2008 Mar; 117(3):227-38. PubMed ID: 18444484
[TBL] [Abstract][Full Text] [Related]
9. Cryotherapy has antifibrotic and regenerative effects on human vocal fold fibroblasts.
Gong T; Zhang C; Kang J; Lamb JJ; Jiang JJ
Laryngoscope; 2019 Apr; 129(4):E143-E150. PubMed ID: 30315572
[TBL] [Abstract][Full Text] [Related]
10. The role of Smad3 in the fibrotic phenotype in human vocal fold fibroblasts.
Branski RC; Bing R; Kraja I; Amin MR
Laryngoscope; 2016 May; 126(5):1151-6. PubMed ID: 26422444
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells have antifibrotic effects on transforming growth factor-β1-stimulated vocal fold fibroblasts.
Hiwatashi N; Bing R; Kraja I; Branski RC
Laryngoscope; 2017 Jan; 127(1):E35-E41. PubMed ID: 27345475
[TBL] [Abstract][Full Text] [Related]
12. The effects of cytosporone-B, a novel antifibrotic agent, on vocal fold fibroblasts.
Hiwatashi N; Mukudai S; Bing R; Branski RC
Laryngoscope; 2018 Dec; 128(12):E425-E428. PubMed ID: 30325029
[TBL] [Abstract][Full Text] [Related]
13. Reversal of the Transcriptome by Prostaglandin E2 during Myofibroblast Dedifferentiation.
Wettlaufer SH; Scott JP; McEachin RC; Peters-Golden M; Huang SK
Am J Respir Cell Mol Biol; 2016 Jan; 54(1):114-27. PubMed ID: 26098591
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 inhibits collagen synthesis in dermal fibroblasts and prevents hypertrophic scar formation in vivo.
Zhao J; Shu B; Chen L; Tang J; Zhang L; Xie J; Liu X; Xu Y; Qi S
Exp Dermatol; 2016 Aug; 25(8):604-10. PubMed ID: 26997546
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen Alters TGF-β1/Smad Signaling in Vocal Fold Injury.
Matsushita H; Mukudai S; Ozawa S; Kinoshita S; Hashimoto K; Kaneko M; Sugiyama Y; Branski RC; Hirano S
Laryngoscope; 2023 Sep; 133(9):2248-2254. PubMed ID: 36250536
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E
Mukherjee S; Sheng W; Michkov A; Sriarm K; Sun R; Dvorkin-Gheva A; Insel PA; Janssen LJ
Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L810-L821. PubMed ID: 30758990
[TBL] [Abstract][Full Text] [Related]
17. Binary regulation of interleukin (IL)-6 production by EP1 and EP2/EP4 subtypes of PGE2 receptors in IL-1beta-stimulated human gingival fibroblasts.
Noguchi K; Shitashige M; Endo H; Kondo H; Ishikawa I
J Periodontal Res; 2002 Feb; 37(1):29-36. PubMed ID: 11842936
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 is activated by airway injury and regulates fibroblast cytoskeletal dynamics.
Sandulache VC; Singh T; Li-Korotky HS; Lo CY; Otteson TD; Barsic M; Dohar JE; Hebda PA
Laryngoscope; 2009 Jul; 119(7):1365-73. PubMed ID: 19444894
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of hepatocyte growth factor and interleukin-6 on transforming growth factor-beta1 mediated vocal fold fibroblast-myofibroblast differentiation.
Vyas B; Ishikawa K; Duflo S; Chen X; Thibeault SL
Ann Otol Rhinol Laryngol; 2010 May; 119(5):350-7. PubMed ID: 20524582
[TBL] [Abstract][Full Text] [Related]
20. Role of EP2 receptors and cAMP in prostaglandin E2 regulated expression of type I collagen alpha1, lysyl oxidase, and cyclooxygenase-1 genes in human embryo lung fibroblasts.
Choung J; Taylor L; Thomas K; Zhou X; Kagan H; Yang X; Polgar P
J Cell Biochem; 1998 Nov; 71(2):254-63. PubMed ID: 9779823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
